FDA clears Pluristem radiation treatment for emergency use

HAIFA, Israel (Reuters) - Pluristem Therapeutics Inc, a developer of placenta-based stem cell products, said the U.S. Food and Drug Administration has cleared the emergency use of its therapy to treat acute radiation exposure in a nuclear event.

from Reuters: Health News https://ift.tt/2KpoI9m
via IFTTT